Not applicableWithdrawnNCT03804125
What this trial is testing
Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer